drugset / Trial / NCT00289263
Maintenance Chemotherapy in Metastatic Breast Cancer
Phase 3
Unknown
524 enrolled
MANTA 1 Study Italian Collaborative Group
Bristol-Myers Squibb · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a randomized, prospective and multicenter phase III study. Two-hundred-sixty-two (262) patients on each arm will be recruited in the study.
Timeline
- Start
- 1998-04
- Primary completion
- —
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 200 mg/m2 | — |